From January 1, 2022 to March 31, 2022, the company has repurchased 1,161,938 shares, representing 4.34% for $5.18 million. With this, the company has completed the repurchase of 1,931,014 shares, representing 7.13% for $8.56 million under the buyback announced on November 17, 2021.
La Jolla Pharmaceutical Company
Equities
LJPC
US5034596040
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
-1.17% | 104B | |
+2.87% | 97.47B | |
+2.13% | 22.25B | |
-14.77% | 21.68B | |
-8.79% | 18.2B | |
-39.98% | 17.02B | |
-13.21% | 16.36B | |
+8.55% | 14.39B | |
+35.75% | 12.37B |